Cellenion introduces customized solutions for single cell omics applications with the cellenCHIP 384

Berlin, Germany, and Lyon, France, June 30, 2021: today, SCIENION and Cellenion announced the launch of the cellenCHIP 384 for single cell omics sample preparation, introducing it as the integral consumable in the new cellenCHIP 384 – 3’RNA-seq Kit for scalable, nanoliter volume library preparation of single cells. The cellenCHIP 384, with its nanowell format, accessory range and options for customization, further extends the automated capabilities of the cellenONE for miniaturization and high throughput workflows. Single cell omics lead to life-changing advances in precision medicine and the technologies greatly enhance analyte profiling possibilities in fields such as oncology.


In combination with cellenONE®, Cellenion’s flagship platform for single cell isolation and nanoliter dispensing, the cellenCHIP 384 provides a step change to improve miniaturized omics protocols for high throughput, sensitivity and costs per single cell and allow high resolution cell imaging.

The cellenCHIP 384 and 3’RNA-seq Kit are fully supported by the launch of the associated cellenCHIP 384 Accessory Kit which provides operators with ease of use for chip handling, precise single cell isolation by the cellenONE, and permits complete sample recovery and pooling by simple centrifugation. Scalability is impressive with the potential to isolate up to 3072 single cells per run, whilst the move from microtiter plates to nanoliter wells enables dramatic volume reductions with no loss of sensitivity.

“The launch of our cellenCHIP platform is an important step as it expands our portfolio for single cell analytics,” said Holger Eickhoff, CEO at SCIENION. “We continue to see the need for a small liquid volume single cell analytics platform around the world, and our novel technology will enable single cell analysis labs to run genomics applications with the cellenCHIP and existing infrastructure. Combining cell imaging with single cell sequencing data, it is also an exciting and versatile technology with many additional future applications.”

“We are thrilled to bring to the market this new consumable that has long been awaited by our cellenONE customers,” said Guilhem Tourniaire, Managing Director at Cellenion. “Allowing both cell imaging capability and nanoliter volume sample preparation, the cellenCHIP 384 will enable the development of novel miniaturized omics protocols. When combined with the cellenONE’s versatility, it will provide a perfect platform for analyses of a range of samples including the more challenging rare cell samples, which, up to now, could not be processed efficiently by other competing technologies.”


PR Contact
Ariel Kramer
Phone +46 72 442 86 57
E-mail: [email protected]


Founded in 2001, SCIENION is a renowned specialist in ultra-low volume precision liquid handling in the pico-liter to micro-liter range, enabling applications from research to high throughput production of assays in diagnostics and life sciences. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION is a complete solution provider offering a unique portfolio of automated precision dispensing systems, readers, consumables, assay development and contract manufacturing services. The company operates from two sites in Germany, Dortmund and Berlin, and has subsidiaries in Arizona, USA; Chichester, UK; and Cellenion in Lyon, France.

SCIENION is part of the CELLINK, the leading bioconvergence company in the world that provides technologies, products and services to create, understand and master biology.

Volmerstraße 7b
D-12489 Berlin
Phone: +49 (0)30 – 6392 1700
Email: [email protected]


About Cellenion
Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single cell isolation and cellular aggregates manipulation. Cellenion has developed cellenONE®, a unique single cell isolation and dispensing technology. It allows high throughput automated dispensing of individual cells from cell suspensions onto any substrates of choice. With no dead volumes and outstanding recovery rates, this platform offers unique capacities for single cell isolation from small biopsies and other clinical samples. Cellenion operates from Lyon, France. The company is a subsidiary of SCIENION GmbH and its products are sold by SCIENION worldwide.

Cellenion SASU
60 Avenue Rockefeller
Bioserra 2
F-69008 Lyon
Phone: +33 (0)9 86 48 70 70
E-mail: [email protected]ellenion.com

More News